O. Mortelé

Optimisation of in vitro sample preparation for LC-MS metabolomics applications on HepaRG cell cultures

T. Vanhaecke, A. Covaci, R. Rodrigues, 2017 .

Optimization of an in vitro gut microbiome biotransformation platform with chlorogenic acid as model compound: From fecal sample to biotransformation product identification.

P. Jorens, A. V. van Nuijs, B. Xavier, 2019, Journal of pharmaceutical and biomedical analysis.

Chlorogenic Acid as a Model Compound for Optimization of an In Vitro Gut Microbiome-Metabolism Model

P. Jorens, A. Breynaert, N. Hermans, 2019, Proceedings.

Suspect and non-target screening workflows to investigate the in vitro and in vivo metabolism of the synthetic cannabinoid 5Cl-THJ-018.

A. Covaci, F. Lai, C. Gys, 2018, Drug testing and analysis.

Evaluation of Saliva as a Matrix for RT-PCR Analysis and Two Rapid Antigen Tests for the Detection of SARS-CoV-2

H. Goossens, H. Jansens, V. Matheeussen, 2022, Viruses.

In vitro Phase I and Phase II metabolism of the new designer benzodiazepine cloniprazepam using liquid chromatography coupled to quadrupole time‐of‐flight mass spectrometry

A. Covaci, F. Lai, C. Gys, 2018, Journal of pharmaceutical and biomedical analysis.

Obesity influences the microbiotic biotransformation of chlorogenic acid.

E. Dirinck, P. Jorens, A. V. van Nuijs, 2021, Journal of pharmaceutical and biomedical analysis.

Demonstrating the involvement of an active efflux mechanism in the intestinal absorption of chlorogenic acid and quinic acid using a Caco-2 bidirectional permeability assay.

S. Lebeer, A. V. van Nuijs, N. Hermans, 2020, Food & function.

Serological response in health care workers after a single dose of SARS-CoV-2 vaccine using six automated SARS-CoV-2 antibody assays

H. Jansens, M. Cuykx, S. Schouwers, 2021, Diagnostic Microbiology and Infectious Disease.